Evaluation of inflammatory cytokines and oxidative stress markers in prostate cancer patients undergoing curative radiotherapy

• Main Authors: Phebe L. Abdel-Messeih, Neveen M. Nosseir, Osama H. Bakhe
• Format: Article
• Language: English
• Published: Termedia Publishing House 2017-05-01
• Series: Central European Journal of Immunology
• Subjects: <i>prostate cancer; oxidative markers; serum cytokines</i>
• Online Access: https://www.termedia.pl/Evaluation-of-inflammatory-cytokines-and-oxidative-stress-markers-in-prostate-cancer-patients-undergoing-curative-radiotherapy,10,29847,1,1.html

Prostate cancer is the second leading cause of cancer-related death in men. The present study was carried out to investigate the radiation response of serum cytokines and oxidative markers to find out if these novel biomarkers have significant applications regarding radiation outcome in prostate cancer patients. Significant elevations of prostatic specific antigen (PSA), asymmetric dimethyl arginine (ADMA) and nitric oxide (NO) were recorded in cancer prostate patients at the time of diagnosis compared to controls. Patients were subjected to radiotherapy post prostatectomy with a total dose of 66 Gy in 33 fractions (5 sessions/week) for 7 weeks. At the end of the seventh week post radiotherapy, ADMA levels were accentuated while the levels of PSA and NO were lower than before therapy. The level of inflammatory cytokines (interleukins IL-4, IL-5 and interferon-gamma) in post radiation therapy patients were significantly elevated compared to both controls and prostate cancer patients. A significant inverse correlation was observed in prostate cancer patients between ADMA and NO. Moreover, a significant inverse correlation in post radiation therapy patients was observed between IL-5 and PSA. These results are highly suggestive that there is a specific cytokine response in patients undergoing curative radiotherapy for prostate cancer.